DELUCCIA ROBERT J - 02 Dec 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Signature
/s/ Robert J. DeLuccia
Issuer symbol
ACXP
Transactions as of
02 Dec 2021
Net transactions value
+$70,066
Form type
4
Filing time
04 Jan 2024, 16:26:24 UTC
Previous filing
22 Nov 2021
Next filing
29 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Gift $0 -40,000 -3.8% $0.000000 1,011,198 02 Dec 2021 Direct F1
transaction ACXP Common Stock Gift $0 -40,000 -4% $0.000000 971,198 12 Dec 2023 Direct F1
transaction ACXP Common Stock Gift $0 -30,000 -3.1% $0.000000 941,198 22 Dec 2023 Direct F1
transaction ACXP Common Stock Options Exercise $70,066 +19,737 +2.1% $3.55 960,935 03 Jan 2024 Direct
holding ACXP Common Stock 3,847 02 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Options Exercise $0 -19,737 -100% $0.000000* 0 03 Jan 2024 Common Stock 19,737 $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person.